Theravance Biopharma, Inc.TBPHNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
1.65%
↑ 100% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
-379.30%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | 1.65% | +102.8% |
| 2024 | -59.73% | +33.6% |
| 2023 | -89.94% | +39.3% |
| 2022 | -148.18% | +64.8% |
| 2021 | -420.95% | -5.1% |
| 2020 | -400.55% | -44.4% |
| 2019 | -277.33% | +21.2% |
| 2018 | -351.89% | +79.1% |
| 2017 | -1684.24% | -365.4% |
| 2016 | -361.86% | - |